> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# New Info Collection Sought for Drug Compounding Guide
- URL: https://www.fdaweb.com/new-info-collection-sought-for-drug-compounding-guide/
- Published: 2018-03-29T12:00:00.000Z
- Updated: 2026-09-14T23:56:10.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141099

*Federal Register* notice: FDA has submitted for OMB approval a new information collection entitled “Guidance for Industry on Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503B of the Federal Food, Drug, and Cosmetic Act.” Section 503B describes conditions that must be met in order for compounded drugs to receive exemptions from certain sections of the FD&C Act. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-03-28/pdf/2018-06169.pdf?ref=fdaweb.com).